Differences in treatment for Alzheimer's disease between urban and rural areas in China. 2022

Bei Li, and Dejun Liu, and Qiaoqin Wan, and Can Sheng, and Xiting Wang, and Fangda Leng, and Qing Peng, and Ting Wang, and Ailian Du, and Feiqi Zhu, and Dunzhu Mima, and Huali Wang, and Hengge Xie, and Zhaoxia Wang, and Haiqiang Jin, and Yongan Sun
Department of Neurology, Peking University First Hospital, Peking University, Beijing, China.

In China, the increasing number of people with Alzheimer's disease (AD) poses a great challenge to families and the country. Economic and cultural differences cause a urban-rural gap in medical resources. This multicenter survey aimed to investigate the real-world practice of disease treatment among people with AD. People with AD and their caregivers from 30 provincial regions in mainland China were enrolled from October 2020 to December 2020 to be surveyed for their treatment experience. Logistic regression was used to explore the factors that influence medication adherence in all areas, urban areas, and rural areas. In this survey, 1,427 participants came from urban areas, and 539 participants came from rural areas. Patients in urban areas were older (mean age 74 vs. 70, p = 0.001), less frequently had mild AD (36.0 vs. 52.1%, p < 0.001), and more often were cared for at professional institutions (8.8 vs. 3.2%, p < 0.001). In terms of pharmacotherapy, 77.8% of people accepted taking lifelong medication, whereas 61.3% of patients insisted on taking medications. Although 72.0% of rural people believed in taking lifelong medication, only 30.0% adhered to drug use. The major factors that influenced medication adherence for all patients with AD were regional distribution (p < 0.001, OR = 6.18, 95% CI: 4.93-7.74) and family earnings (p = 0.003, OR = 1.22, 95% CI: 1.07-1.38). In rural areas, family earnings (p = 0.008, OR = 1.44, 95% CI: 1.10-1.89) and severity of AD (p = 0.033, OR = 1.31, 95% CI: 1.02-1.68) were the main factors. Family earnings (p = 0.038, OR = 1.16, 95% CI: 1.01-1.34) was the only factor among urban areas. Among all non-pharmaceutical activities except for cognitive intervention, the participation rates of rural patients were significantly higher than those of urban patients (p < 0.05). Although national progress has been made in the public awareness of disease treatment, adequate diagnosis and medication adherence need to be prompted, especially in rural areas. Furthermore, lifelong treatment should be improved based on regional characteristics through the joint efforts of the government, health workers, and social volunteers.

UI MeSH Term Description Entries

Related Publications

Bei Li, and Dejun Liu, and Qiaoqin Wan, and Can Sheng, and Xiting Wang, and Fangda Leng, and Qing Peng, and Ting Wang, and Ailian Du, and Feiqi Zhu, and Dunzhu Mima, and Huali Wang, and Hengge Xie, and Zhaoxia Wang, and Haiqiang Jin, and Yongan Sun
December 1998, Community dental health,
Bei Li, and Dejun Liu, and Qiaoqin Wan, and Can Sheng, and Xiting Wang, and Fangda Leng, and Qing Peng, and Ting Wang, and Ailian Du, and Feiqi Zhu, and Dunzhu Mima, and Huali Wang, and Hengge Xie, and Zhaoxia Wang, and Haiqiang Jin, and Yongan Sun
June 2000, Burns : journal of the International Society for Burn Injuries,
Bei Li, and Dejun Liu, and Qiaoqin Wan, and Can Sheng, and Xiting Wang, and Fangda Leng, and Qing Peng, and Ting Wang, and Ailian Du, and Feiqi Zhu, and Dunzhu Mima, and Huali Wang, and Hengge Xie, and Zhaoxia Wang, and Haiqiang Jin, and Yongan Sun
December 2023, European journal of trauma and emergency surgery : official publication of the European Trauma Society,
Bei Li, and Dejun Liu, and Qiaoqin Wan, and Can Sheng, and Xiting Wang, and Fangda Leng, and Qing Peng, and Ting Wang, and Ailian Du, and Feiqi Zhu, and Dunzhu Mima, and Huali Wang, and Hengge Xie, and Zhaoxia Wang, and Haiqiang Jin, and Yongan Sun
January 2003, Salud publica de Mexico,
Bei Li, and Dejun Liu, and Qiaoqin Wan, and Can Sheng, and Xiting Wang, and Fangda Leng, and Qing Peng, and Ting Wang, and Ailian Du, and Feiqi Zhu, and Dunzhu Mima, and Huali Wang, and Hengge Xie, and Zhaoxia Wang, and Haiqiang Jin, and Yongan Sun
August 1991, Chinese medical journal,
Bei Li, and Dejun Liu, and Qiaoqin Wan, and Can Sheng, and Xiting Wang, and Fangda Leng, and Qing Peng, and Ting Wang, and Ailian Du, and Feiqi Zhu, and Dunzhu Mima, and Huali Wang, and Hengge Xie, and Zhaoxia Wang, and Haiqiang Jin, and Yongan Sun
August 2007, Twin research and human genetics : the official journal of the International Society for Twin Studies,
Bei Li, and Dejun Liu, and Qiaoqin Wan, and Can Sheng, and Xiting Wang, and Fangda Leng, and Qing Peng, and Ting Wang, and Ailian Du, and Feiqi Zhu, and Dunzhu Mima, and Huali Wang, and Hengge Xie, and Zhaoxia Wang, and Haiqiang Jin, and Yongan Sun
August 2019, BMC psychiatry,
Bei Li, and Dejun Liu, and Qiaoqin Wan, and Can Sheng, and Xiting Wang, and Fangda Leng, and Qing Peng, and Ting Wang, and Ailian Du, and Feiqi Zhu, and Dunzhu Mima, and Huali Wang, and Hengge Xie, and Zhaoxia Wang, and Haiqiang Jin, and Yongan Sun
March 2019, Colombia medica (Cali, Colombia),
Bei Li, and Dejun Liu, and Qiaoqin Wan, and Can Sheng, and Xiting Wang, and Fangda Leng, and Qing Peng, and Ting Wang, and Ailian Du, and Feiqi Zhu, and Dunzhu Mima, and Huali Wang, and Hengge Xie, and Zhaoxia Wang, and Haiqiang Jin, and Yongan Sun
June 2018, Colombia medica (Cali, Colombia),
Bei Li, and Dejun Liu, and Qiaoqin Wan, and Can Sheng, and Xiting Wang, and Fangda Leng, and Qing Peng, and Ting Wang, and Ailian Du, and Feiqi Zhu, and Dunzhu Mima, and Huali Wang, and Hengge Xie, and Zhaoxia Wang, and Haiqiang Jin, and Yongan Sun
November 2018, Scandinavian journal of public health,
Copied contents to your clipboard!